How a drug used to treat Parkinson’s disease might affect the brain
Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to treat Parkinson’s disease.
Read More
Researchers lay groundwork for at-home cervical cancer screening
Researchers are one step closer to developing a simple, at-home test to prevent cervical cancer or treat it early, shows a study from University of Florida Health Cancer Center and Purdue University researchers.
Turning off the enzyme behind high cholesterol may pave path for new therapies for multiple inflammatory diseases
Scientists at The University of Texas at Arlington have identified a new enzyme that can be “turned off” to help the body maintain healthy cholesterol levels—a significant development that could lead to new treatments for diseases that affect millions of Americans.
Diabetes drug may serve as alternative treatment option for hydrocephalus
A drug commonly used to treat type 2 diabetes may reduce excess fluid in the brains of patients with hydrocephalus, which could help treat the disease less invasively than current treatments, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
Kennedy’s advisers back flu vaccination, but not shots with a rarely used preservative
The Trump administration’s new vaccine advisers on Thursday endorsed this fall’s flu vaccinations for just about every American—but only if they use certain shots free of an ingredient antivaccine groups have falsely tied to autism.
Tailored TB treatment based on disease severity may improve patient outcomes
A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide.
Symptoms aren’t sole predictors of brain injury from moyamoya
Moyamoya disease—a rare, progressive condition that narrows the brain’s blood vessels—leads to an increased risk of stroke and other neurological conditions. Doctors treating children with moyamoya often face difficult decisions about treatment, notably deciding whether to perform revascularization, a surgery to bypass the narrowed blood vessels and restore blood flow.
How changes in the central amygdala drive anxiety
Researchers at the Max Planck Florida Institute for Neuroscience have discovered how loss of a gene strongly associated with autism and macrocephaly (large head size) rewires circuits and alters behavior.
Cancer drug candidate developed using supercomputing and AI blocks tumor growth without toxic side effects
A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect.
New study identifies brain networks underlying psychopathy
A recent study has shed light on the brain structure differences associated with psychopathy—a condition known to be one of the strongest predictors of persistent violent behavior.